메뉴 건너뛰기




Volumn 112, Issue 6, 2005, Pages 1170-1171

Uniocular drug trial [3] (multiple letters)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LATANOPROST; ANTIHYPERTENSIVE AGENT;

EID: 20444388347     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.11.022     Document Type: Letter
Times cited : (2)

References (4)
  • 1
    • 1442275272 scopus 로고    scopus 로고
    • The uniocular drug trial and second-eye response to glaucoma medications
    • T. Realini R.D. Fechtner S.P. Atreides S. Gollance The uniocular drug trial and second-eye response to glaucoma medications Ophthalmology 111 2004 421 426
    • (2004) Ophthalmology , vol.111 , pp. 421-426
    • Realini, T.1    Fechtner, R.D.2    Atreides, S.P.3    Gollance, S.4
  • 2
    • 0027251292 scopus 로고
    • Individual variability in the diurnal intraocular pressure curve
    • J.T. Wilensky D.K. Gieser M.L. Dietsche Individual variability in the diurnal intraocular pressure curve Ophthalmology 100 1993 940 944
    • (1993) Ophthalmology , vol.100 , pp. 940-944
    • Wilensky, J.T.1    Gieser, D.K.2    Dietsche, M.L.3
  • 3
    • 0023748067 scopus 로고
    • Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension) glaucoma
    • M.J. Cartwright D.R. Anderson Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension) glaucoma Arch Ophthalmol 106 1988 898 900
    • (1988) Arch Ophthalmol , vol.106 , pp. 898-900
    • Cartwright, M.J.1    Anderson, D.R.2
  • 4
    • 0017595572 scopus 로고
    • Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma
    • T.J. Zimmerman H.E. Kaufman Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma Arch Ophthalmol 95 1977 601 604
    • (1977) Arch Ophthalmol , vol.95 , pp. 601-604
    • Zimmerman, T.J.1    Kaufman, H.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.